Bank of New York Mellon’s Acrivon Therapeutics ACRV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,635
| Closed | -$56.1K | – | 4118 |
|
|
2025
Q1 | $56.1K | Hold |
27,635
| – | – | ﹤0.01% | 4027 |
|
|
2024
Q4 | $166K | Sell |
27,635
-1,874
| -6% | -$11.3K | ﹤0.01% | 3962 |
|
|
2024
Q3 | $207K | Sell |
29,509
-7,123
| -19% | -$49.9K | ﹤0.01% | 3886 |
|
|
2024
Q2 | $212K | Buy |
36,632
+12,219
| +50% | +$70.9K | ﹤0.01% | 3917 |
|
|
2024
Q1 | $175K | Sell |
24,413
-382
| -2% | -$2.73K | ﹤0.01% | 3958 |
|
|
2023
Q4 | $122K | Hold |
24,795
| – | – | ﹤0.01% | 4046 |
|
|
2023
Q3 | $237K | Hold |
24,795
| – | – | ﹤0.01% | 3897 |
|
|
2023
Q2 | $321K | Buy |
24,795
+1,958
| +9% | +$25.4K | ﹤0.01% | 3789 |
|
|
2023
Q1 | $290K | Buy |
+22,837
| New | +$290K | ﹤0.01% | 3756 |
|